LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 A443654
0.37
uM
LJP6
 1
I22
 72
hr
 1401 1151 4223 0.2726 -0.0888
SK-BR-3 A443654
0.37
uM
LJP6
 2
I22
 72
hr
 1401 1287 4223 0.3048 -0.0406
SK-BR-3 A443654
0.37
uM
LJP6
 3
I22
 72
hr
 1401 1098 4223 0.2600 -0.1076
SK-BR-3 OSI-027
0.37
uM
LJP6
 1
E10
 72
hr
 1401 1993 4223 0.4719 0.2096
SK-BR-3 OSI-027
0.37
uM
LJP6
 2
E10
 72
hr
 1401 1668 4223 0.3950 0.0944
SK-BR-3 OSI-027
0.37
uM
LJP6
 3
E10
 72
hr
 1401 1819 4223 0.4307 0.1480
SK-BR-3 XMD11-85h
0.37
uM
LJP6
 1
P22
 72
hr
 1401 3876 4223 0.9178 0.8770
SK-BR-3 XMD11-85h
0.37
uM
LJP6
 2
P22
 72
hr
 1401 3578 4223 0.8473 0.7714
SK-BR-3 XMD11-85h
0.37
uM
LJP6
 3
P22
 72
hr
 1401 3758 4223 0.8899 0.8352
SK-BR-3 HG-6-64-01
0.37
uM
LJP6
 1
M04
 72
hr
 1401 3512 4223 0.8316 0.7480
SK-BR-3 HG-6-64-01
0.37
uM
LJP6
 2
M04
 72
hr
 1401 2826 4223 0.6692 0.5049
SK-BR-3 HG-6-64-01
0.37
uM
LJP6
 3
M04
 72
hr
 1401 3619 4223 0.8570 0.7859
SK-BR-3 WH-4-025
0.37
uM
LJP5
 1
O10
 72
hr
 1401 4931 4223 1.1676 1.2509
SK-BR-3 WH-4-025
0.37
uM
LJP5
 2
O10
 72
hr
 1401 969 4223 0.2295 -0.1533
SK-BR-3 WH-4-025
0.37
uM
LJP5
 3
O10
 72
hr
 1401 4248 4223 1.0059 1.0088
SK-BR-3 WZ-4-145
0.37
uM
LJP6
 1
J22
 72
hr
 1401 2306 4223 0.5461 0.3206
SK-BR-3 WZ-4-145
0.37
uM
LJP6
 2
J22
 72
hr
 1401 2246 4223 0.5318 0.2993
SK-BR-3 WZ-4-145
0.37
uM
LJP6
 3
J22
 72
hr
 1401 2297 4223 0.5439 0.3174
SK-BR-3 XMD16-144
0.37
uM
LJP5
 1
M10
 72
hr
 1401 1706 4223 0.4040 0.1079
SK-BR-3 XMD16-144
0.37
uM
LJP5
 2
M10
 72
hr
 1401 1604 4223 0.3798 0.0718
SK-BR-3 XMD16-144
0.37
uM
LJP5
 3
M10
 72
hr
 1401 1447 4223 0.3426 0.0161
SK-BR-3 Brivanib
0.37
uM
LJP5
 1
P16
 72
hr
 1401 3798 4223 0.8993 0.8493
SK-BR-3 Brivanib
0.37
uM
LJP5
 2
P16
 72
hr
 1401 4105 4223 0.9720 0.9582
SK-BR-3 Brivanib
0.37
uM
LJP5
 3
P16
 72
hr
 1401 4712 4223 1.1158 1.1733
SK-BR-3 Buparlisib
0.37
uM
LJP5
 1
H04
 72
hr
 1401 1887 4223 0.4468 0.1721